Drug Development

driven by
the ambition
to cure


Discover our 18 studies

From discovery to phase III in oncology and bacterial infections


Our Drug Development Business Model

Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners to maximize patient access across the globe.

Debiopharm Business Model presentation

In-licensing Deal Focus

Our in-licensed compounds benefit from smart drug development leading to better patient treatment & value creation. We look for promising oncology and antibacterial compounds to transform them into valuable treatments. Want to partner with us? Discover our selection criteria

Universities, Biotech, Big pharma
Main areas
Oncology, Bacterial Infections
Development stages
From candidate to clinical phase I
Small molecules, antibodies and peptides
Leadership team

Discover the members who guide and bring long-term vision to drug development

Product portfolio

Discover the treatments we offer via our commercial partners worldwide

Learn more

Discover our latest scientific publications and posters

Read more
Contact us

Would like to partner with us? Got a question or a comment? Get in touch!

Get in touch